Champions Oncology Inc Stock
?
Your prediction
Champions Oncology Inc Stock
Pros and Cons of Champions Oncology Inc in the next few years
Pros
Cons
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | -0.410% | 0.402% | -7.407% | -25.926% | -13.793% | -16.667% | -36.306% |
| Evolus Inc | -1.600% | -6.881% | -2.359% | -30.062% | 3.303% | -16.593% | -42.843% |
| Heron Therapeutics Inc. | 0.160% | -3.021% | 5.293% | -80.767% | -67.145% | -69.752% | -96.826% |
| Rhythm Pharmaceuticals | -1.560% | -7.000% | 22.368% | 31.915% | -0.535% | 564.286% | 481.250% |
News
KinderCare Learning Companies Q1 Earnings Call Highlights
KinderCare Learning Companies (NYSE:KLC) reported modest first-quarter revenue growth while management said lower enrollment in its early childhood education centers continued to pressure
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo
DI Women's and Men's Finals to be Featured in ‘Breakaway: Polo in College' on ESPN
WEST PALM BEACH, FLA. / ACCESS Newswire / April 2, 2026 / U.S. Polo Assn., the official sports brand of
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D
HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology,

